SFMBT1 and schizophrenia: Taken together, we provided convergent and consistent lines of evidence that support rs2535629 confers risk of schizophrenia by modulating SFMBT1 expression, a gene whose expression perturbation might be involved in schizophrenia by affecting neurodevelopment and synaptic morphologies (two key pathogenic characteristics of schizophrenia).